MedPath

Antioxidant Profile in Patients With Systemic Sclerosis and Periodontitis

Not Applicable
Active, not recruiting
Conditions
Systemic Sclerosis
Periodontitis
Registration Number
NCT05215431
Lead Sponsor
University of Belgrade
Brief Summary

The aim of the research will be to compare periodontal status and level of antioxidants in unstimulated saliva of systemic sclerosis patients with periodontitis and systemically healthy periodontitis patients.

Twenty systemic sclerosis patients with periodontitis (SS group) and twenty systemically healthy periodontitis patients (P group) will be enrolled in the present study. The results may indicate higher periodontal destruction and antioxidant perturbations in unstimulated saliva of systemic sclerosis patients with periodontitis compared to systemically healthy periodontitis patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • established diagnoses of systemic sclerosis and periodontitis (study group),
  • age ≥ 18
  • presence of minimum 12 teeth
Exclusion Criteria
  • concurrent inflammatory mediated rheumatic diseases
  • pregnancy or lactation
  • active cigarette smokers
  • a history of periodontal, antibiotics or non-steroidal drug therapy in the past 6 months.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Probing depth (PD)one day

Measuring the PD by periodontal probe, measured in mm

Gingival margin level (GML)one day

Measuring the GML by periodontal probe, measured in mm

The degree of gingival inflammationone day

The degree of gingival inflammation was assessed using the Loe and Silness (LSGI) gingival index.

plaque index (PI)one day

Evaluation of oral hygiene status was recorded with a Silness Loe plaque index (PI).

The concentration of vascular endothelial growth factor (VEGF)baseline and two months after periodontal treatment

The level of VEGF were determined using commercial ELISA (enzyme-linked immunosorbent assay) kits.

The concentration of transforming growth factor beta (TGF-β)baseline and two months after periodontal treatment

The level of TGF-β in gingival crevicular fluid was determined using commercial ELISA (enzyme-linked immunosorbent assay) kits at the Implant Research Center, School of Dental Medicine, University of Belgrade, following the manufacturer\'s instructions.

The concentration of interleukin (IL)-17baseline and two months after periodontal treatment

interleukin (IL)-17 was determined using commercial ELISA (enzyme-linked immunosorbent assay) kits at the Implant Research Center, School of Dental Medicine, University of Belgrade, following the manufacturer\'s instructions.

The concentration of glutathion peroxidase (GPX)one day

Activity level of GPX, determined using the colorimetric method and commercial kits.

The concentration of uric acid (UA)one day

Activity level of UA, determined using the colorimetric method and commercial kits.

The concentration of superoxide dismutase (SOD)one day

Activity level of SOD, determined using the colorimetric method and commercial kits.

Clinical attachment level (CAL)one day

Measuring the CAL by periodontal probe, measured in mm

The concentration of tumor necrosis factor alphabaseline and two months after periodontal treatment
The concentration of C reactive proteinbaseline and two months after periodontal treatment
Erythrocyte sedimentation rate (ESR)baseline and two months after periodontal treatment
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Periodontology and Oral medicine, School of Dental Medicine, University of Belgrade

🇷🇸

Belgrade, Serbia

Department of Periodontology and Oral medicine, School of Dental Medicine, University of Belgrade
🇷🇸Belgrade, Serbia
Stefan Sredojevic
Contact
+381113317988
sredojevic43@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.